Cargando…
Using Genetics To Dissect SARS-CoV-2 Infection
To uncover the key cellular pathways associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infectivity, Daniloski and coworkers used CRISPR-based whole-genome screening. Their results could propose new or repositioned drugs for the ongoing fight against COVID-19.
Autores principales: | Brest, Patrick, Mograbi, Baharia, Hofman, Paul, Milano, Gerard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7689311/ https://www.ncbi.nlm.nih.gov/pubmed/33309104 http://dx.doi.org/10.1016/j.tig.2020.11.007 |
Ejemplares similares
-
Host Polymorphisms May Impact SARS-CoV-2 Infectivity
por: Brest, Patrick, et al.
Publicado: (2020) -
Host genetic variability and determinants of severe COVID-19
por: Brest, Patrick, et al.
Publicado: (2023) -
More light on cancer and COVID-19 reciprocal interaction
por: Brest, Patrick, et al.
Publicado: (2021) -
COVID-19 vaccination and cancer immunotherapy: should they stick together?
por: Brest, Patrick, et al.
Publicado: (2021) -
The Mystery of MIS-C Post-SARS-CoV-2 Infection
por: Brodsky, Nina N., et al.
Publicado: (2020)